Ron Winslow discusses the latest developments in colorectal cancer (CRC) screening and how Exact Sciences is combating the growing screening crisis. On the heels of the USPSTF draft CRC screening guidelines, read more about screening options including Cologuard. https://exas.co/3a2UzM9 Cologuard is intended to screen adults 45 and older at average risk for colorectal cancer. Do not use Cologuard if you have had adenomas, have inflammatory bowel disease and certain hereditary syndromes, or a pers
0:27
Ron Winslow discusses the latest developments in colorectal cancer (CRC) screening and how Exact Sciences is combating the growing screening crisis. On the heels of the USPSTF draft CRC screening guidelines, read more about screening options including Cologuard. https://exas.co/3a2UzM9 Cologuard is intended to screen adults 45 and older at average risk for colorectal cancer. Do not use Cologuard if you have had adenomas, have inflammatory bowel disease and certain hereditary syndromes, or a pers
1.6K viewsFeb 8, 2021
FacebookExact Sciences
On November 8, 2017, Exact Sciences broke ground on a new lab to support the continued growth of Cologuard. See it from the air and ground, and hear about our ongoing work to help more people get screened for colon cancer. | Exact Sciences
1:19
On November 8, 2017, Exact Sciences broke ground on a new lab to support the continued growth of Cologuard. See it from the air and ground, and hear about our ongoing work to help more people get screened for colon cancer. | Exact Sciences
19.7K viewsDec 13, 2017
FacebookExact Sciences
Exact Sciences | LinkedIn
Exact Sciences | LinkedIn
May 11, 2024
linkedin.com
Exact Sciences Corporation Announces Jeff Elliott Plans to Step Down as Chief Financial Officer in 2024
Exact Sciences Corporation Announces Jeff Elliott Plans to Step Down as Chief Financial Officer in 2024
Jan 7, 2024
marketscreener.com
Newly published research shows that more women with early-stage breast cancer can use a genomic test called the Oncotype DX Breast Recurrence Score® test to help guide their treatment choices with their physician. Do you know how genomic testing works? | Exact Sciences
1:22
Newly published research shows that more women with early-stage breast cancer can use a genomic test called the Oncotype DX Breast Recurrence Score® test to help guide their treatment choices with their physician. Do you know how genomic testing works? | Exact Sciences
1.3K viewsDec 7, 2021
FacebookExact Sciences
We never cut corners. Advancing earlier detection – the right way – means that we use advanced technology and rigorous science to develop solutions that work. | Exact Sciences
0:44
We never cut corners. Advancing earlier detection – the right way – means that we use advanced technology and rigorous science to develop solutions that work. | Exact Sciences
1.1K viewsJun 12, 2019
FacebookExact Sciences
Exact Sciences Corp. Demonstrates Power of Multi-Cancer Early Detection Approach with Data Presentation At the 2022 European Society for Medical Oncology Congress
Exact Sciences Corp. Demonstrates Power of Multi-Cancer Early Detection Approach with Data Presentation At the 2022 European Society for Medical Oncology Congress
Sep 10, 2022
marketscreener.com
0:21
The journey to transform cancer care has only just begun. With groundbreaking science, a powerful platform, and key partnerships, we’re reimagining what’s possible for patients and their families. This isn’t just innovation – it’s impact. | Exact Sciences
168.3K views6 months ago
FacebookExact Sciences
0:28
Exact Sciences Launches the Cancerguard™ Test | Exact Sciences
3 views8 months ago
linkedin.com
0:33
Introducing the Class of 2023-24 #ExactSciencesAthletes! We’re thrilled to share that we’re partnering with eight student-athletes from University of Wisconsin-Madison who share in our passion for science, health care, and giving back to the community. Meet the team and learn more: http://ms.spr.ly/61869NK6o Wisconsin Badgers | Exact Sciences
762 viewsOct 31, 2023
FacebookExact Sciences
0:49
Exact Sciences Athletes Class of 2024 🎓 Throughout the 2023-24 academic year, Exact Sciences is partnering with eight UW student-athletes pursuing science-related degrees. The program provides these student-athletes with the opportunity to engage with the company on various initiatives, including social media outreach, community events, career coaching and more, and is tailored to each individual’s unique interests. #ExactSciencesAthletes | Wisconsin Badgers
183.3K viewsJan 3, 2024
FacebookWisconsin Badgers
Exact Sciences expansion to change Research Park culture
Aug 13, 2024
channel3000.com
0:07
Exact Sciences helps people make informed decisions across the cancer continuum. Our new Oncotype MAP™ test may help connect patients with lung cancer to the right targeted therapies. This Lung Cancer Awareness Month, let’s take on cancer together and raise awareness about this deadly disease: https://exas.co/3nK08TC | Exact Sciences
516 viewsNov 23, 2020
FacebookExact Sciences
0:54
It was a busy year at Exact Sciences! As 2024 winds down, join us for a look back at some of our favorite moments: https://www.exactsciences.com/news-events/articles/our-best-of-2024 | Exact Sciences
635 viewsDec 30, 2024
FacebookExact Sciences
16:22
Cologuard Order Form ≡ Fill Out Printable PDF Forms Online
Aug 24, 2021
formspal.com
1:00
Exact Sciences lays off 4% of company including Madison positions
9 months ago
wmtv15news.com
0:53
Routine screening is key to earlier cancer detection. When cancer is found early, it may be easier to treat. In 2022, get ahead of cancer. Talk to your doctor about screening options that may be right for you. | Exact Sciences
1.1K viewsJan 27, 2022
FacebookExact Sciences
0:57
See how Cologuard changed these doctors' practices to get patients screened for colon cancer. | Exact Sciences
51.5K viewsOct 16, 2017
FacebookExact Sciences
2:01
Our pipeline is expanding at a rapid rate – starting with promising new biomarkers for the early detection of liver cancer. | Exact Sciences
71K viewsMay 31, 2018
FacebookExact Sciences
What to know about Exact Sciences. The Madison company was sold to Abbot for $23 billion.
6 months ago
bluewaterhealthyliving.com
0:51
If you’ve received a Cologuard® kit and you’re unsure why, we can explain. There are an estimated 60 million adults in the U.S. who remain unscreened for colorectal cancer (CRC).* To help improve this gap in preventive care, we’re helping health plans reach patients in the most direct way possible: by proactively sending Cologuard® kits to those who are eligible and overdue for CRC screening. This gap closure program helps enable patients to take control of their health and proactively screen fo
2K views7 months ago
FacebookExact Sciences
0:55
Meet Oncotype DX® patient ambassador Nina: a retired fourth-grade math and science teacher and avid sports cards collector who enjoys sketching, journaling, and spending time at the farmhouse with her family and friends. It was a shock to her when she was diagnosed with breast cancer at the age of 64. Thankfully, her Oncotype DX Breast Recurrence Score® result was 21, indicating that she would likely not benefit from the addition of chemotherapy and could proceed with hormone-blocking therapy an
473 views7 months ago
FacebookExact Sciences
0:43
Last week, we celebrated the grand opening of our discovery campus lab. The new facility represents how strongly we believe in our community. Together, we are making a difference by helping detect cancer earlier. | Exact Sciences
2.5K viewsJul 1, 2019
FacebookExact Sciences
0:25
Get screened for colon cancer in just minutes. Watch the story to see how. For average risk adults 50 years and older. Rx Only. See the full story here: https://www.facebook.com/pg/exactsci/videos/?ref=page_internal | Exact Sciences
1.3K viewsJul 3, 2017
FacebookExact Sciences
3:22
Some patients are resistant to being screened for colon cancer. These doctors weigh in on how offering eligible patients Cologuard, a noninvasive stool-DNA test for average risk adults age 50 and above, helped them encourage more patients to get screened. | Exact Sciences
85.5K viewsSep 11, 2017
FacebookExact Sciences
2:51
“I got screened, and thank goodness I did.” Watch Dorothy’s story and learn more about the importance of colon cancer screening and early detection. | Exact Sciences
35.5K viewsAug 22, 2017
FacebookExact Sciences
0:22
📣 Applications for our summer 2026 internship program are officially open! At Exact Sciences, interns tackle real-world projects that help change lives by bringing fresh energy, ideas, and creativity to our teams. Explore opportunities across the business and be part of work that makes a difference. Apply today: http://spr.ly/6187AoYXx | Exact Sciences
1.3K views7 months ago
FacebookExact Sciences
0:11
Our Oncodetect™ test is here! With the launch of the Oncodetect test, we're advancing the field of molecular residual disease (MRD) testing, providing patients and their healthcare providers with the insights needed to help make informed decisions throughout the treatment process. Find out more: http://spr.ly/61822VsFm | Exact Sciences
1.7K viewsApr 22, 2025
FacebookExact Sciences
1:57
The Oncotype DX® test has redefined personalized medicine by helping more than a million breast cancer patients make informed treatment choices. Findings published in The New England Journal of Medicine will help impact even more women with node-positive early-stage breast cancer. Watch now: https://exas.co/3FsCynD | Exact Sciences
1.2K viewsDec 28, 2021
FacebookExact Sciences
1:42
Breast cancer care has come a long way, and genomic tests like the Oncotype DX Breast Recurrence Score® test have helped transform outcomes for patients. Discover how the Oncotype DX® test helped Katherine–and over 1.8 million others–make more informed treatment decisions: http://spr.ly/6185fB0Jx | Exact Sciences
297 views10 months ago
FacebookExact Sciences
See more
Static thumbnail place holder